Elanco Animal Health Incorporated
ELAN
$24.88
-$1.21-4.64%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 6.22% | 3.08% | -0.18% | 1.42% | 0.50% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 6.22% | 3.08% | -0.18% | 1.42% | 0.50% |
| Cost of Revenue | 5.94% | 2.48% | 0.84% | 2.31% | 3.73% |
| Gross Profit | 6.44% | 3.57% | -1.01% | 0.70% | -2.01% |
| SG&A Expenses | 8.79% | 6.53% | 5.19% | 1.71% | 2.19% |
| Depreciation & Amortization | 3.04% | -0.19% | -2.77% | -4.57% | -3.83% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 6.55% | 3.53% | 1.96% | 1.46% | 2.35% |
| Operating Income | 0.78% | -4.26% | -29.51% | 0.82% | -22.36% |
| Income Before Tax | -145.90% | -103.88% | 147.67% | 141.52% | 140.84% |
| Income Tax Expenses | -94.67% | -125.12% | 1,345.45% | 1,381.82% | 316.67% |
| Earnings from Continuing Operations | -168.64% | -82.44% | 134.58% | 128.65% | 127.46% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -168.64% | -82.44% | 134.58% | 128.65% | 127.46% |
| EBIT | 0.78% | -4.26% | -29.51% | 0.82% | -22.36% |
| EBITDA | 3.30% | 4.63% | -6.76% | -0.35% | -9.47% |
| EPS Basic | -168.18% | -82.39% | 134.46% | 128.54% | 127.38% |
| Normalized Basic EPS | 821.74% | 170.63% | -12.08% | 110.05% | -192.00% |
| EPS Diluted | -171.77% | -84.83% | 133.66% | 127.84% | 126.71% |
| Normalized Diluted EPS | 813.64% | 168.83% | -11.76% | 109.84% | -222.22% |
| Average Basic Shares Outstanding | 0.47% | 0.43% | 0.38% | 0.34% | 0.35% |
| Average Diluted Shares Outstanding | 0.53% | 0.49% | 0.79% | 0.57% | 0.58% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |